Target, Home Depot,...
Health Care: Health Services
BG Medicine Inc. (BGMD: NASDAQ)
$1.69 0.00 | 0.00%
05/17/13 - 04:00 PM ET
Company Balance Sheet
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Assets | ||||
|---|---|---|---|---|
| Cash and Equivalents | 12.79M | 23.87M | 2.42M | 8.34M |
| Receivables | 395.00K | 115.00K | 786.00K | 278.00K |
| Inventories | 447.00K | 212.00K | 0.00 | 0.00 |
| Other Current Assets | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 14.58M | 25.32M | 3.62M | 10.92M |
| Property, Plant & Equipment, Gross | 4.98M | 5.28M | 7.53M | 7.45M |
| Accumulated Depreciation & Depletion | 4.79M | 4.98M | 6.92M | 6.47M |
| Property, Plant & Equipment, Net | 197.00K | 301.00K | 604.00K | 983.00K |
| Intangibles | 372.00K | 456.00K | 541.00K | 625.00K |
| Other Non-Current Assets | 96.00K | 37.00K | 2.27M | 102.00K |
| Total Non-Current Assets | 665.00K | 794.00K | 3.41M | 1.71M |
| Liabilities & Shareholder Equity | ||||
| Total Assets | 15.24M | 26.11M | 7.03M | 12.62M |
| Accounts Payable | 1.11M | 487.00K | 1.38M | 1.03M |
| Short Term Debt | 3.24M | 0.00 | 96.00K | 1.16M |
| Other Current Liabilities | 0.00 | 0.00 | 6.28M | 0.00 |
| Total Current Liabilities | 8.32M | 5.20M | 12.10M | 4.90M |
| Long Term Debt | 6.61M | 0.00 | 0.00 | 96.00K |
| Deferred Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Non-Current Liabilities | 5.00K | 15.00K | 248.00K | 471.00K |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Non-Current Liabilities | 6.62M | 15.00K | 72.34M | 71.63M |
| Total Liabilities | 14.93M | 5.22M | 84.44M | 76.53M |
| Preferred Stock Equity | 0.00 | 0.00 | 1.71M | 1.71M |
| Common Stock Equity | 309.00K | 20.89M | -79.12M | -65.61M |
| Common Par | 21.00K | 20.00K | 3.00K | 3.00K |
| Additional Paid In Capital | 137.38M | 134.19M | 16.62M | 12.97M |
| Cumulative Translation Adjustment | 0.00 | 0.00 | 0.00 | 0.00 |
| Retained Earnings | -137.09M | -113.32M | -95.74M | -78.58M |
| Treasury Stock | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Equity Adjustments | 0.00 | 0.00 | 0.00 | -2.00K |
| Total Capitalization | 6.92M | 20.89M | -77.41M | -63.80M |
| Total Equity | 309.00K | 20.89M | -77.41M | -63.90M |
| Total Liabilities & Stock Equity | 15.24M | 26.11M | 7.03M | 12.62M |
| Total Common Shares Outstanding | 20.52M | 19.97M | 18.39M | 18.39M |
| Preferred Shares | 0.00 | 0.00 | 1.14M | 1.14M |
| Treasury Shares | 0.00 | 0.00 | 0.00 | 0.00 |
| Basic Weighted Shares Outstanding | 20.22M | 17.64M | 2.97M | 12.47M |
| Diluted Weighted Shares Outstanding | 20.22M | 17.64M | 2.97M | 12.47M |
| Number of Employees | 30 | 39 | 39 | NA |
| Number of Part-Time Employees | 0 | 0 | 0 | NA |
Portfolios with BGMD
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks With Big Insider Buy...
- ContributorUnder-$10 Setting Up To Tra...
- Contributor8 Health Care Stocks With R...
Latest BGMD Headlines from TheStreet
- BG Medicine Welcomes CE Mark For Galectin-3 Test 04.10.13 | 08:04 am
- BG Medicine Reports Fourth Quarter And Full Year 2012 Financial Results And Provides 2013 Outlook 03.13.13 | 07:03 am
- BG Medicine To Announce Fourth Quarter And Year-End 2012 Financial Results And Host Conference Call On Wednesday, March 13, 2013 03.06.13 | 08:03 am
- BG Medicine Highlights Role Of Galectin-3 Testing In Combating Hospital Readmissions At The American College Of Cardiology's (ACC) 62nd Annual Scientific Session & Expo 03.06.13 | 08:03 am
- BG Medicine, Inc. To Present At Cowen And Company 33rd Annual Health Care Conference 02.27.13 | 08:02 am
- BG Medicine, Inc. Announces Publication Of Two Studies Supporting Repeat Galectin-3 Testing In Heart Failure Patients 02.27.13 | 08:02 am
- 5 Stocks With Big Insider Buying 02.06.13 | 12:02 pm
- BG Medicine, Inc. Announces Closing Of Public Offering And Exercise Of Over-Allotment Option 01.30.13 | 04:01 pm
- BG Medicine, Inc. Prices $12.0 Million Public Offering Of Common Stock 01.25.13 | 09:01 am
- BG Medicine, Inc. Enters Into $12 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC 01.24.13 | 04:01 pm
Press Releases for BGMD
- Abbott's Galectin-3 Test Provides Doctors In Europe With New Tool For Assessing The Prognosis Of Chronic Heart Failure Patients - PR Newswire 04.10.13 | 08:04 am
- Health Diagnostic Laboratory, Inc. (HDL, Inc.) Announces Availability Of Galectin-3 Testing Service In Partnership With BG Medicine - PR Newswire 03.24.11 | 08:03 am
- BG Medicine Announces Exercise Of Underwriters’ Over-Allotment Option And Closing Of Initial Public Offering - Business Wire 02.09.11 | 04:02 pm
- BG Medicine Announces Pricing Of Initial Public Offering - Business Wire 02.04.11 | 08:02 am
Partner Headlines for BGMD
- Pre-Market Most Active for Dec 12, 2012 : TLAB, QQQ, NRF, STM, BAC, NOK, LLY, AIG, SIRI, BGMD, FB, AAPL - NASDAQ 12.12.12 | 01:12 pm
- 4 Undervalued And Technically Oversold Healthcare Penny Stocks Poised To Bounce - Seeking Alpha 11.20.12 | 09:11 am
- UPDATE: Ladenburg Thalmann Raises PT to $16.50 on BG Medicine - Benzinga 02.14.12 | 01:02 pm
- Market Update - Benzinga 01.09.12 | 09:01 am
